Epidemiology and natural history of HCV infection

B Hajarizadeh, J Grebely, GJ Dore - Nature reviews Gastroenterology & …, 2013 - nature.com
Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …

Natural history of acute and chronic hepatitis C

B Maasoumy, H Wedemeyer - Best practice & research Clinical …, 2012 - Elsevier
Hepatitis C virus (HCV) infection remains a major global health burden. Hepatitis C causes
significant liver-related morbidity and mortality due to hepatic decompensation and …

EASL recommendations on treatment of hepatitis C: final update of the series☆

JM Pawlotsky, F Negro, A Aghemo, M Berenguer… - Journal of …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

JD Stanaway, AD Flaxman, M Naghavi, C Fitzmaurice… - The Lancet, 2016 - thelancet.com
Background With recent improvements in vaccines and treatments against viral hepatitis, an
improved understanding of the burden of viral hepatitis is needed to inform global …

[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021

KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Determinants of viral clearance and persistence during acute hepatitis C virus infection

R Thimme, D Oldach, KM Chang, C Steiger… - The Journal of …, 2001 - rupress.org
The virological and immunological features of hepatitis C virus (HCV) infection were studied
weekly for 6 months after accidental needlestick exposure in five health care workers, four of …

Treatment of acute hepatitis C with interferon alfa-2b

E Jaeckel, M Cornberg, H Wedemeyer… - … England Journal of …, 2001 - Mass Medical Soc
Background In people who are infected with the hepatitis C virus (HCV), chronic infection
often develops and is difficult to eradicate. We sought to determine whether treatment during …

[HTML][HTML] Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid–amplification testing

SL Stramer, SA Glynn, SH Kleinman… - … England Journal of …, 2004 - Mass Medical Soc
Background Testing of blood donors for human immunodeficiency virus type 1 (HIV-1) and
hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the …

A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

MP Busch, SA Glynn, SL Stramer, DM Strong… - …, 2005 - Wiley Online Library
BACKGROUND: Estimates for human immunodeficiency virus (HIV)‐1 and hepatitis C virus
(HCV) transfusion‐transmitted risks have relied on incidence derived from repeat donor …

Acute hepatitis C

A Maheshwari, S Ray, PJ Thuluvath - The Lancet, 2008 - thelancet.com
Symptomatic acute hepatitis C occurs in only about 15% of patients who are infected with
hepatitis C virus (HCV). Acute hepatitis C is most often diagnosed in the setting of post …